Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China, Duke Cancer Institute, Duke University Medical Center, 905 Lasalle Street, Durham, NC 27710, USA, Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA, Department of Gastroenterological Surgery, St Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan and Department of Gastrointestinal Medical Oncology and Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Duke Cancer Institute, Duke University Medical Center, 905 Lasalle Street, Durham, NC 27710, USA.
Carcinogenesis. 2014 Sep;35(9):2031-8. doi: 10.1093/carcin/bgu142. Epub 2014 Jul 2.
Functional genetic variants of DNA repair genes may alter the host DNA repair capacity, and thus influence efficiency of therapies. We genotyped eight potentially functional single nucleotide polymorphisms (SNPs) in genes (i.e. ERCC1, XPA, XPC, XPD and XPG) involved in the nucleotide excision repair (NER) pathway in 496 Japanese gastric cancer patients, and assessed overall survival and recurrence-free survival. The combined effects of risk genotypes of these eight SNPs in Japanese patients were further replicated in 356 North-American gastric cancer patients. In Japanese patients, we found that the XPC rs2228000 TT genotype was associated with shorter overall survival [hazards ratio (HR) = 1.75, 95% confidence interval (95% CI) = 1.07-2.86] and recurrence-free survival (HR = 2.17, 95% CI = 1.19-3.95), compared with CC/CT genotypes, and the XPG rs17655 CC genotype was associated with shorter overall survival (HR = 1.60, 95% CI = 1.08-2.36), compared with GG/CG genotypes. The number of observed risk genotypes in the combined analysis was associated with shorter overall survival and recurrence-free survival in a dose-response manner (P(trend) = 0.006 and P(trend) < 0.000) in Japanese patients; specifically, compared with those with ≤1 risk genotypes, those with ≥2 risk genotypes showed markedly shorter overall survival (HR = 1.79, 95% CI = 1.18-2.70) and recurrence-free survival (HR = 2.80, 95% CI = 1.66-4.73). The association between ≥2 risk genotypes and shorter overall survival was not significant (HR = 1.26, 95% CI = 0.82-1.94) in North-American patients, but the trends were similar in these two groups of patients. These data show that functional SNPs in NER core genes may impact survival in Japanese gastric cancer patients.
DNA 修复基因的功能遗传变异可能会改变宿主的 DNA 修复能力,从而影响治疗的效果。我们对参与核苷酸切除修复 (NER) 途径的 8 个基因(即 ERCC1、XPA、XPC、XPD 和 XPG)中的 8 个潜在功能单核苷酸多态性 (SNP) 在 496 名日本胃癌患者中进行了基因分型,并评估了总生存和无复发生存。在 356 名北美胃癌患者中进一步复制了这些 8 个 SNP 的风险基因型在日本患者中的综合影响。在日本患者中,我们发现 XPC rs2228000 TT 基因型与总生存时间较短相关[风险比 (HR) = 1.75,95%置信区间 (95% CI) = 1.07-2.86]和无复发生存率(HR = 2.17, 95% CI = 1.19-3.95),与 CC/CT 基因型相比,XPG rs17655 CC 基因型与总生存时间较短相关(HR = 1.60, 95% CI = 1.08-2.36),与 GG/CG 基因型相比。在日本患者中,联合分析中观察到的风险基因型数量与总生存和无复发生存呈剂量反应关系(趋势 P 值=0.006 和 P 值<0.000);具体而言,与≤1 个风险基因型相比,≥2 个风险基因型的患者总生存时间明显缩短(HR = 1.79,95% CI = 1.18-2.70)和无复发生存(HR = 2.80,95% CI = 1.66-4.73)。在北美患者中,≥2 个风险基因型与总生存时间较短之间的关联不显著(HR = 1.26,95% CI = 0.82-1.94),但这两组患者的趋势相似。这些数据表明,NER 核心基因中的功能性 SNP 可能会影响日本胃癌患者的生存。